A detailed history of Cibc Private Wealth Group, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 3,784 shares of NEO stock, worth $65,387. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,784
Previous 4,099 7.68%
Holding current value
$65,387
Previous $56,000 1.79%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$13.4 - $17.73 $4,221 - $5,584
-315 Reduced 7.68%
3,784 $55,000
Q2 2024

Aug 09, 2024

SELL
$13.01 - $15.77 $34,957 - $42,373
-2,687 Reduced 39.6%
4,099 $56,000
Q1 2024

May 10, 2024

SELL
$14.06 - $16.79 $73,196 - $87,408
-5,206 Reduced 43.41%
6,786 $106,000
Q4 2023

Feb 13, 2024

BUY
$11.67 - $20.73 $139,946 - $248,594
11,992 New
11,992 $194,000
Q3 2023

Nov 13, 2023

BUY
$12.15 - $17.85 $145,459 - $213,700
11,972 New
11,972 $147,000
Q2 2023

Nov 21, 2023

BUY
$14.1 - $19.83 $181,001 - $254,557
12,837 New
12,837 $206,000
Q2 2023

Aug 10, 2023

BUY
$14.1 - $19.83 $181,001 - $254,557
12,837 New
12,837 $206,000
Q1 2023

Nov 21, 2023

BUY
$9.09 - $19.45 $27,024 - $57,824
2,973 Added 24.83%
14,945 $260,000
Q1 2023

May 11, 2023

SELL
$9.09 - $19.45 $21,716 - $46,466
-2,389 Reduced 13.78%
14,945 $260,000
Q4 2022

Jun 01, 2023

BUY
$6.45 - $12.07 $15,409 - $28,835
2,389 Added 15.99%
17,334 $160,000
Q4 2022

Feb 13, 2023

SELL
$6.45 - $12.07 $20,885 - $39,082
-3,238 Reduced 15.74%
17,334 $160,000
Q3 2022

Nov 14, 2022

BUY
$7.86 - $12.91 $161,695 - $265,584
20,572 New
20,572 $177,000
Q2 2022

Aug 03, 2022

SELL
$7.06 - $13.97 $31,798 - $62,920
-4,504 Reduced 14.51%
26,532 $216,000
Q1 2022

May 16, 2022

SELL
$12.15 - $35.28 $53,204 - $154,491
-4,379 Reduced 12.36%
31,036 $377,000
Q4 2021

Feb 08, 2022

SELL
$30.49 - $48.49 $41,618 - $66,188
-1,365 Reduced 3.71%
35,415 $1.21 Million
Q3 2021

Nov 12, 2021

SELL
$41.66 - $52.52 $103,525 - $130,512
-2,485 Reduced 6.33%
36,780 $1.77 Million
Q2 2021

Aug 16, 2021

BUY
$36.62 - $51.69 $16,662 - $23,518
455 Added 1.17%
39,265 $1.77 Million
Q1 2021

May 12, 2021

SELL
$41.56 - $59.88 $233,816 - $336,884
-5,626 Reduced 12.66%
38,810 $1.87 Million
Q4 2020

Feb 12, 2021

SELL
$36.08 - $56.47 $93,266 - $145,974
-2,585 Reduced 5.5%
44,436 $2.39 Million
Q3 2020

Nov 03, 2020

BUY
$33.26 - $40.48 $1.56 Million - $1.9 Million
47,021 New
47,021 $1.74 Million
Q2 2020

Aug 13, 2020

SELL
$24.21 - $31.02 $1.37 Million - $1.76 Million
-56,652 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$20.5 - $34.53 $220,129 - $370,783
-10,738 Reduced 15.93%
56,652 $1.56 Million
Q4 2019

Jan 30, 2020

SELL
$18.96 - $29.84 $23,169 - $36,464
-1,222 Reduced 1.78%
67,390 $1.97 Million
Q3 2019

Oct 16, 2019

SELL
$19.12 - $26.24 $225,558 - $309,553
-11,797 Reduced 14.67%
68,612 $1.31 Million
Q2 2019

Jul 31, 2019

SELL
$19.57 - $24.1 $107,008 - $131,778
-5,468 Reduced 6.37%
80,409 $1.76 Million
Q1 2019

May 10, 2019

BUY
$12.14 - $20.46 $77,356 - $130,371
6,372 Added 8.01%
85,877 $1.76 Million
Q4 2018

Feb 05, 2019

SELL
$11.24 - $18.5 $69,688 - $114,700
-6,200 Reduced 7.23%
79,505 $1 Million
Q3 2018

Nov 14, 2018

SELL
$12.5 - $15.38 $750 - $922
-60 Reduced 0.07%
85,705 $1.32 Million
Q2 2018

Aug 02, 2018

BUY
$7.99 - $14.05 $3,275 - $5,760
410 Added 0.48%
85,765 $1.12 Million
Q1 2018

May 17, 2018

SELL
$7.23 - $8.76 $105,377 - $127,677
-14,575 Reduced 14.59%
85,355 $696,000
Q4 2017

Feb 12, 2018

BUY
$8.02 - $11.18 $16,521 - $23,030
2,060 Added 2.1%
99,930 $885,000
Q3 2017

Nov 14, 2017

BUY
$9.11 - $11.26 $891,595 - $1.1 Million
97,870
97,870 $1.09 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.17B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.